Cargando…
甲状腺转录因子在宣威肺腺癌中的表达及临床意义
BACKGROUND AND OBJECTIVE: The present study aims to detect the expressions of the thyroid transcription factor 1 (TTF-1) mRNA and protein in Xuanwei lung adenocarcinoma line (XWLC-05). We also investigated the relationship of TTF-1 with Ki-67 protein and analyzed the prognostic value of the TTF-1 pr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015132/ https://www.ncbi.nlm.nih.gov/pubmed/23514941 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.03 |
_version_ | 1783334335572606976 |
---|---|
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: The present study aims to detect the expressions of the thyroid transcription factor 1 (TTF-1) mRNA and protein in Xuanwei lung adenocarcinoma line (XWLC-05). We also investigated the relationship of TTF-1 with Ki-67 protein and analyzed the prognostic value of the TTF-1 protein in Xuanwei lung adenocarcinoma patients. METHODS: The expression of TTF-1 mRNA was evaluated by quantitative real-time RT-PCR (qRT-PCR), while proteins of TTF-1 and Ki-67 were detected by immunohistochemistry in XWLC-05. The expressions of TTF-1 and Ki-67 was detected in 96 resected cases of Xuanwei lung adenocarcinoma by immunohistochemistry from January 2008 to March 2012. RESULTS: TTF-1 mRNA was low and protein was absent in XWLC-05. The expression of Ki67 protein was 100% (high proliferative activity) in XWLC-05. All samples were Xuanwei lung adenocarcinoma (n=96) and TNM stages were Ⅰ-Ⅱ 66% (63/96) and Ⅲ 34% (33/96). Immunohistochemical analysis showed the expression of TTF-1 in 89 (93%) of 96 and Ki-67 in 69 (70%) of 96. The positive rate of TTF-1 protein was 38 (96%) of 39 in well-differentiated phenotype and 51 (89%) 57 in moderately/poorly-differentiated phenotype. Patients with strong immunohistochemical expression of TTF-1 were statistically associated with well-differentiated phenotype (P=0.002), has inverse correlation with Ki-67 expression (P=0.01), and no correlation with age, sex, smoking history, and stages. The result from the Kaplan-Meier survival analysis showed that stages TTF-1 and Ki-67 were significantly associated with the prognosis of Xuanwei lung adenocarcinoma patients. The median progression-free survival in patients with Ⅰ-Ⅱ stages, strong positive expression TTF-1 and negative, and weak expressions Ki-67 groups was remarkably higher than those patients with Ⅲ stage (46 months vs 32 months, P=0.001), negative and weak expressions TTF-1 (45 months vs 35 months, P=0.036) and strong positive expression Ki-67 groups (46 months vs 40 months, P=0.048), respectively. CONCLUSION: Our results presented here suggest that TTF-1 may serve as a tumor suppressor gene based on its inverse correlation with Ki-67 proliferative activity. Patients with strong TTF-1 protein expression group tend to have a significantly better prognosis than patients with negative and weak TTF-1 protein expression group in Xuanwei lung adenocarcinoma. |
format | Online Article Text |
id | pubmed-6015132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60151322018-07-06 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: The present study aims to detect the expressions of the thyroid transcription factor 1 (TTF-1) mRNA and protein in Xuanwei lung adenocarcinoma line (XWLC-05). We also investigated the relationship of TTF-1 with Ki-67 protein and analyzed the prognostic value of the TTF-1 protein in Xuanwei lung adenocarcinoma patients. METHODS: The expression of TTF-1 mRNA was evaluated by quantitative real-time RT-PCR (qRT-PCR), while proteins of TTF-1 and Ki-67 were detected by immunohistochemistry in XWLC-05. The expressions of TTF-1 and Ki-67 was detected in 96 resected cases of Xuanwei lung adenocarcinoma by immunohistochemistry from January 2008 to March 2012. RESULTS: TTF-1 mRNA was low and protein was absent in XWLC-05. The expression of Ki67 protein was 100% (high proliferative activity) in XWLC-05. All samples were Xuanwei lung adenocarcinoma (n=96) and TNM stages were Ⅰ-Ⅱ 66% (63/96) and Ⅲ 34% (33/96). Immunohistochemical analysis showed the expression of TTF-1 in 89 (93%) of 96 and Ki-67 in 69 (70%) of 96. The positive rate of TTF-1 protein was 38 (96%) of 39 in well-differentiated phenotype and 51 (89%) 57 in moderately/poorly-differentiated phenotype. Patients with strong immunohistochemical expression of TTF-1 were statistically associated with well-differentiated phenotype (P=0.002), has inverse correlation with Ki-67 expression (P=0.01), and no correlation with age, sex, smoking history, and stages. The result from the Kaplan-Meier survival analysis showed that stages TTF-1 and Ki-67 were significantly associated with the prognosis of Xuanwei lung adenocarcinoma patients. The median progression-free survival in patients with Ⅰ-Ⅱ stages, strong positive expression TTF-1 and negative, and weak expressions Ki-67 groups was remarkably higher than those patients with Ⅲ stage (46 months vs 32 months, P=0.001), negative and weak expressions TTF-1 (45 months vs 35 months, P=0.036) and strong positive expression Ki-67 groups (46 months vs 40 months, P=0.048), respectively. CONCLUSION: Our results presented here suggest that TTF-1 may serve as a tumor suppressor gene based on its inverse correlation with Ki-67 proliferative activity. Patients with strong TTF-1 protein expression group tend to have a significantly better prognosis than patients with negative and weak TTF-1 protein expression group in Xuanwei lung adenocarcinoma. 中国肺癌杂志编辑部 2013-03-20 /pmc/articles/PMC6015132/ /pubmed/23514941 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.03 Text en 版权所有©《中国肺癌杂志》编辑部2013 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 临床研究 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title_full | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title_fullStr | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title_full_unstemmed | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title_short | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
title_sort | 甲状腺转录因子在宣威肺腺癌中的表达及临床意义 |
topic | 临床研究 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015132/ https://www.ncbi.nlm.nih.gov/pubmed/23514941 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.03 |
work_keys_str_mv | AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì AT jiǎzhuàngxiànzhuǎnlùyīnzizàixuānwēifèixiànáizhōngdebiǎodájílínchuángyìyì |